Navigation Links
Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship
Date:12/12/2008

a small, flexible catheter that delivers medication directly into the intrathecal space where fluid flows around the spinal cord.

Following the surgery, Jason's spasms and spasticity decreased drastically. His leg and back muscles relaxed, and he regained control of his body.

"The device has worked tremendously for me," Fowler said. "With my spasms under control, I was able to do everyday things more easily, and I was also able to start training and competing again."

After his motorcycle accident, Jason became a member of the wheelchair racing team at the University of Illinois. Competing on his college team reignited Jason's passion and soon he was setting his sights on increasingly difficult feats. To date he has competed in 140 road races, 29 marathons and 19 triathlons, including the Ironman World Championship. He completed the 2008 Ironman World Championship in 11:29:52 as the fastest American in [the handcycle] division.

Jason's athletic achievements are not representative of the typical ITB Therapy(SM) (Intrathecal Baclofen Therapy) experience. However, his story is inspirational. He is one extraordinary individual who was able to reach a personal goal through the help of this therapy. As you read it, please bear in mind the athletic achievements are specific to this particular individual and are not representative of the typical ITB Therapy patient. As with all therapies, results may vary, and this therapy may not be for you. Talk to your doctor.

To learn more about spasticity caused by spinal cord injury and ITB Therapy, please visit www.medtronic.com/your-health/spinal-cord-injury-disease/index.htm. You can also read more of Jason's story by visiting www.jasonfowlerracing.com.


'/>"/>
SOURCE Medtronic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism
2. Video: Combined Veterinary and Pet Owner Efforts Help Pet Lose Big
3. Video: Childhood Influenza Immunization Coalition Supports Second Annual Childrens Flu Vaccination Day
4. Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day
5. Video: America Votes Crest Whitening Expressions Is FanTaste-ic!
6. Video: PowerBar Unveils New Global Website Connecting Sports Communities
7. Video: Intel Announces its First Home Medical Device in the United Kingdom to Better Connect Clinicians With Patients
8. Video: CVS/pharmacy and National Council on Aging Help Seniors to Find the Right Prescription for Medicare Savings
9. Video: Nation Gets a D as March Of Dimes Releases Premature Birth Report Card
10. Video: MassMutual Enhances Whole Life Insurance Products - Provides Flexibility, Guarantees
11. Video: Ultrasound Systems Can Produce Clearer Images With TIs New Family of Fully Integrated High-Voltage Pulsers and Switches
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Pharmacy Technician Employment Increasing Up to 32% By 2016 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6HMS Holdings Corp to Present at William Blair 29th Annual Growth Stock Conference 48209 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 2University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 1University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 2University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 3